Table 3.
Treatment and outcomes of COVID-19 patients and newborns.
| Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | All patients (n = 8) (%) |
|---|---|---|---|---|---|---|---|---|---|
| Medications received during ECMO support: | |||||||||
| Antiviral | N | N | N | N | N | N | N | N | 0 (0) |
| Antibiotics | N | Y | Y | Y | Y | Y | Y | Y | 7 (87.5) |
| Glucocorticoids | Y | Y | Y | Y | Y | Y | Y | N | 7 (87.5) |
| Tracheostomy | N | N | N | Y | Y | Y | N | N | 3 (37.5) |
| Total tracheostomy days | 0 | 0 | 0 | 28 | 9 | 11 | 0 | 0 | 8 ± 8.5 |
| Total days on ventilator | 7 | 36 | 8 | 24 | 16 | 18 | 9 | 4 | 15 ± 10 |
| Off anticoagulation > 24 h | N | Y | N | Y | Y | Y | Y | N | 5 (62.5) |
| Total days in ICU | 15 | 47 | 11 | 54 | 25 | 74 | 15 | 7 | 31 ± 22.8 |
| Total hospital days | 24 | 76 | 14 | 57 | 25 | 81 | 19 | 8 | 38 ± 27.1 |
| Weaned (Y/N) | Y | Y | Y | Y | Y | Y | Y | Y | 8 (100) |
| Survived to discharge | Y | Y | Y | Y | Y | Y | Y | Y | 8 (100) |
| Newborn survival | Y | Y | Y | Y | Y | Y | Y | Y | 8 (100) |
| Newborn hospital discharge | Y | Y | Y | Y | Y | Y | Y | Y | 8 (100) |
ICU: intensive care unit; Y: yes; N: no.
The data are presented as mean ± SD or number (%).